Sandu Pharmaceuticals Limited (BOM:524703)

India flag India · Delayed Price · Currency is INR
44.90
-1.21 (-2.62%)
At close: Apr 29, 2026
-10.86%
Market Cap 445.47M
Revenue (ttm) 671.50M
Net Income (ttm) 20.52M
Shares Out 9.66M
EPS (ttm) 2.11
PE Ratio 21.86
Forward PE n/a
Dividend 0.80 (1.73%)
Ex-Dividend Date Sep 18, 2025
Volume 2,913
Average Volume 6,273
Open 45.00
Previous Close 46.11
Day's Range 43.00 - 46.00
52-Week Range 30.00 - 58.80
Beta 0.07
RSI 74.88
Earnings Date Jun 3, 2026

About Sandu Pharmaceuticals

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers sandu mahasudarshan kadha no 1, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasav... [Read more]

Industry Pharmaceutical Preparations
Founded 1899
Employees 303
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524703
Full Company Profile

Financial Performance

In fiscal year 2025, Sandu Pharmaceuticals's revenue was 671.92 million, a decrease of -0.13% compared to the previous year's 672.81 million. Earnings were 15.52 million, an increase of 6.19%.

Financial Statements

News

There is no news available yet.